Tips for searching:
• You have to select a product and type at least 2 words to activate the search
• Use only words that are specific to the information you are looking for
• Avoid typing questions or sentences
Please do not use this field to report adverse events or product complaints. Adverse events and product complaints should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow card in the Google play or Apple app store. Adverse events and product complaints should also be reported to Lilly: please call Lilly UK on 01256 315 000.
Emgality ® (galcanezumab)
This information is intended for UK registered healthcare professionals only in response to your search for information. For current information for all Lilly products, including Summaries of Product Characteristics, Patient Information Leaflets and Instructions for Use, please visit: www.medicines.org.uk
Emgality® (galcanezumab) Pen: Information on Needle
The pre-filled pen comes with a 27 gauge (thin wall) x 12.7 mm permanently built in needle.
Content overview
Can the needle be changed?
The needle is built into the cartridge that is inside the pen and cannot be changed or removed. The needle or needle attachment must not be touched.1
Is medicine dripping from the needle normal when the base cap is removed?
A drop of liquid on the tip of the needle is normal and will not affect the dose.2
Does the needle retract after the injection has been administered?
When the medicine is completely delivered, the needle begins to travel upward (retract). The patient may feel the needle travel upwards in the pen. The second loud click is heard right before the needle stops retracting. The whole process of the needle retraction occurs very quickly.1
If the needle does not retract after the injection the needle must not be touched and the base cap must not be replaced. The pen must be stored in a safe place to avoid an accidental needlestick injury. Patients can contact their doctor, pharmacist or nurse for instructions on how to return the pen.2
The instructions for using the pen included with the Package Leaflet, must be followed carefully. The pre-filled pen is for total use only.3
After training, patients may self-inject galcanezumab if a healthcare professional determines that it is appropriate. 3
How can the user avoid damaging the needle?
Make sure the pen is locked. Leave the base cap on until you are ready to inject.
When you are ready to inject, twist off the base cap and throw it away in the bin. Do not touch the needle.
Do not put the base cap back on – this could damage the needle.2
References
1Data on file, Eli Lilly and Company and/or one of its subsidiaries.
2Emgality [instructions for use]. Eli Lilly Nederland B.V., The Netherlands.
3Emgality [summary of product characteristics]. Eli Lilly Nederland B.V., The Netherlands.
Date of Last Review: 04 December 2024